( October 17, 2024, 9:34 AM EDT) -- WASHINGTON, D.C. — Two former Acclarent Inc. executives convicted of distributing and misbranding medical devices sold in interstate commerce lost their bid for a U.S. Supreme Court review of their convictions when the court on Oct. 7 denied their petition to review whether the U.S. Food and Drug Administration’s “intended use” regulations violated their constitutional rights....